Monitored Therapeutics Revenue and Competitors

Dublin, OH

Location

N/A

Total Funding

Estimated Revenue & Valuation

  • Monitored Therapeutics's estimated annual revenue is currently $7.8M per year.(i)
  • Monitored Therapeutics's estimated revenue per employee is $288,185

Employee Data

  • Monitored Therapeutics has 27 Employees.(i)
  • Monitored Therapeutics grew their employee count by 8% last year.

Monitored Therapeutics's People

NameTitleEmail/Phone
1
CEOReveal Email/Phone
2
Technical Product OwnerReveal Email/Phone
3
Chief Science OfficerReveal Email/Phone
4
Chief Technology OfficerReveal Email/Phone
5
Chief Operating OfficerReveal Email/Phone
6
Director Clinical OperationsReveal Email/Phone
7
Director, Sales and MarketingReveal Email/Phone
8
Clinical Education Specialist / Project ManagerReveal Email/Phone
9
Product ManagerReveal Email/Phone
10
Quality Assurance SpecialistReveal Email/Phone
Competitor NameRevenueNumber of EmployeesEmployee GrowthTotal FundingValuation
#1
$470.6M15924%N/AN/A
#2
$16.3M530%N/AN/A
#3
$7.8M310%N/AN/A
#4
$3.8M1417%N/AN/A
#5
$21.1M68-1%N/AN/A
#6
$70M2798%N/AN/A
#7
$4M130%N/AN/A
#8
$135.3M5390%N/AN/A
#9
$11.5M4211%N/AN/A
#10
$8.8M3535%N/AN/A
Add Company

What Is Monitored Therapeutics?

Monitored Therapeutics Inc. (MTI) is Respiratory Telehealthcare Company focused on COPD, Asthma, Lung Transplant, and Cystic Fibrosis with four proprietary products - GoSpiro® Home Spirometer, GoHome™ Patient Health Monitor, GoClinic, GoECG and the MTI CarePortal™. MTI extends Access to Care to the patient and provider through a standardized platform, increasing Patient Engagement, Drug Adherence and Quality of Life while decreasing overall healthcare costs by keeping patients in their homes and out of the hospital. The GoSpiro® is an FDA 510(k) cleared spirometer capable of lab-quality results in the home.

keywords:N/A

N/A

Total Funding

27

Number of Employees

$7.8M

Revenue (est)

8%

Employee Growth %

N/A

Valuation

N/A

Accelerator

Company NameRevenueNumber of EmployeesEmployee GrowthTotal Funding
#1
$7.3M27-4%N/A
#2
$8.1M27-13%N/A
#3
$2.5M2713%N/A
#4
$4.2M2713%N/A
#5
N/A2780%N/A